Data from the assay component TOX21_PXR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PXR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor target family, where the subfamily is non-steroidal.
Data from the assay component TOX21_TR_LUC_GH3_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component TOX21_PR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity an be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_PXRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PXRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
TOX21_RT_HEK293_GLO_40hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
TOX21_RT_HEK293_GLO_32hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
Data from the assay component TOX21_ERR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.
TOX21_RT_HEK293_GLO_24hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
Data from the assay component TOX21_SHH_3T3_GLI3_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SHH_3T3_GLI3_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GLI3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.
Data from the assay component TOX21_AR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component TOX21_MMP_ratio was analyzed into 1 assay endpoint. The assay endpoin, TOX21_MMP_ratio, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of membrane potential reporter, gain-of-signal activity can be used to understand changes in the signaling. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.
Data from the assay component TOX21_ARE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_ARE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.
TOX21_RT_HEK293_GLO_16hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
The assay component endpoint  TOX21_CASP3_CHO_viability uses a type of viability reporter where loss-of-signal activity can be used to understand changes in viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.
Data from the assay component TOX21_ERb_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_TR_LUC_GH3_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
The assay component endpoint  TOX21_PXR_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.
TOX21_RT_HEPG2_FLO_40hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
TOX21_RT_HEK293_GLO_08hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
Data from the assay component ATG_NRF2_ARE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NRF2_ARE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFE2L2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
TOX21_SHH_3T3_GLI3_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_ERa_LUC_VM7_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_RT_HEPG2_FLO_32hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
TOX21_ERb_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_ERa_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component TOX21_PGC_ERR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PGC_ERR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.
TOX21_RT_HEK293_FLO_40hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
Data from the assay component TOX21_Aromatase_Inhibition was analyzed into 1 assay endpoint. This assay endpoint, TOX21_Aromatase_Inhibition, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP19A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is steroidogenesis-related.
TOX21_SHH_3T3_GLI3_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_ERb_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_ERR_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_SBE_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor receptor intended target family, where subfamily is transforming growth factor beta.
TOX21_Aromatase_Inhibition_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_FXR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_FXR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
TOX21_AR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_RT_HEPG2_FLO_24hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
TOX21_PGC_ERR_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.
TOX21_RT_HEK293_FLO_32hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
Data from the assay component ATG_PXR_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_PXR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_CAR_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_HRE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_AP1_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AP1_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene JUN|FOS|JUN. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
TOX21_RXR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_CAR_Agonist_viabillity used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_VDR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_PPARg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_VDRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_VDRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component TOX21_RORg_LUC_CHO_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RORg_LUC_CHO_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1F3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.
Data from the assay component TOX21_RAR_LUC_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RAR_LUC_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RARA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where subfamily is non-steroidal.
Data from the assay component ACEA_ER_AUC_viability was analyzed  in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_PPARd_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_RT_HEK293_FLO_24hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
Data from the assay component ATG_ERE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_RORg_LUC_CHO_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_RT_HEPG2_GLO_16hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
TOX21_RT_HEPG2_GLO_24hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
Data from the assay component TOX21_GR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand gene activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_RT_HEPG2_GLO_08hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
TOX21_PR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_ERa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_PR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_p53_BLA_p2_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.
TOX21_H2AX_HTRF_CHO_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_CAR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_CAR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1I3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.
Data from the assay component TOX21_PPARg_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
TOX21_AhR_LUC_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_p53_BLA_p4_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_RT_HEPG2_FLO_16hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
Data from the assay component TOX21_p53_BLA_p4_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.
The assay component endpoint  TOX21_CASP3_HEPG2_viability uses a type of viability reporter where loss-of-signal activity can be used to understand changes in viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.
Data from the assay component TOX21_CAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_CAR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1I3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.
TOX21_RT_HEPG2_GLO_32hr_ctrl_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_FLO_08hr_viability
TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_p53_BLA_p1_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.
Data from the assay component TOX21_AhR_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AhR_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AHR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic helix-loop-helix protein.
Data from the assay component ATG_MRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_MRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MTF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.
Data from the assay component TOX21_p53_BLA_p5_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.
TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_p53_BLA_p3_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_p53_BLA_p3_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter,  gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.
TOX21_RT_HEK293_FLO_16hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
TOX21_RT_HEK293_FLO_08hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_DR4_LXR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_DR4_LXR_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2 and NR1H3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_ARE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_RT_HEPG2_GLO_40hr_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_Ahr_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Ahr_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain or loss-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AHR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.
Data from the assay component ATG_AP_1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AP_1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOS and JUN. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
TOX21_MMP_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component LTEA_HepaRG_CYP1A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP1A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component BSK_hDFCGF_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_hDFCGF_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.
TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_p53_BLA_p3_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_PPRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA and PPARD and PPARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
TOX21_GR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ACEA_AR_antagonist_80hr was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, measures of the cells for loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_p53_BLA_p2_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component BSK_3C_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_3C_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.
TOX21_PPARd_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_PPARd_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ACEA_AR_antagonist_AUC_viability was analyzed  in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_AR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
TOX21_NFkB_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_HIF1a_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HIF1a_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HIF1A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.
Data from the assay component ATG_Oct_MLP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Oct_MLP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene POU2F1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is POU domain protein.
Data from the assay component TOX21_HSE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_HSE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is heat shock protein.
TOX21_RT_HEPG2_FLO_08hr_viability used a dead cell DNA stain where an increase in measured fluorescence indicated a loss of cell viability.  The assay component endpoint is part of a kinetic analysis of cell death with additional exposure times measured in other assay components as well as live cells measured with a vital dye, e.g. TOX21_RT_HEK293_GLO_08hr_viability
Data from the assay component TOX21_H2AX_HTRF_CHO_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_H2AX_HTRF_CHO_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene H2AFX. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is histone.
Data from the assay component LTEA_HepaRG_CYP2B6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2B6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
TOX21_FXR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_AP1_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle target family, where the subfamily is cytotoxicity.
TOX21_p53_BLA_p1_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_SREBP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_SREBP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SREBF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.
Data from the assay component TOX21_HDAC_Inhibition was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HDAC_Inhibition, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HDAC1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.
TOX21_ELG1_LUC_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_RXRb_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_RXRb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component BSK_3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.
TOX21_VDR_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component TOX21_VDR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_EGR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_EGR_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene EGR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.
Data from the assay component TOX21_GR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ACEA_AR_AUC_viability was analyzed  in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_Xbp1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Xbp1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene XBP1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
TOX21_PPARg_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component LTEA_HepaRG_CYP1A2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP1A2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component TOX21_ERa_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_ISRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ISRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene IRF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is interferon regulatory factors.
Data from the assay component ACEA_ER_80hr was analyzed into 1 assay endpoint. 
This assay endpoint, ACEA_ER_80hr_Positive, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, measures of the cells for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component BSK_3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component BSK_hDFCGF_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
TOX21_RAR_LUC_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_Pax6_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Pax6_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PAX6. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is paired box protein.
Data from the assay component BSK_SAg_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.
Data from the assay component BSK_SAg_CD40 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD40, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.
TOX21_FXR_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
TOX21_ESRE_BLA_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component BSK_4H_Eotaxin3 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_Eotaxin3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL26. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component BSK_hDFCGF_CollagenIII was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_CollagenIII, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene COL3A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is collagen.
Data from the assay component ATG_BRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_BRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SMAD1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is Smad protein.
Data from the assay component BSK_CASM3C_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_CASM3C_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.
Data from the assay component ATG_TCF_b_cat_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TCF_b_cat_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TCF7 and TCF7L2 and LEF1 and TCF7L1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein.
Data from the assay component TOX21_TSHR_HTRF_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.
Data from the assay component BSK_hDFCGF_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
Data from the assay component BSK_SAg_CD38 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD38, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD38. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is other cytokine.
Data from the assay component ATG_RORE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RORE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORA and RORB and RORC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.
Data from the assay component ATG_PBREM_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PBREM_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component BSK_hDFCGF_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.
Data from the assay component BSK_LPS_CD40 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_CD40, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.
Data from the assay component BSK_SAg_CD69 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD69, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD69. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.
Data from the assay component LTEA_HepaRG_CYP2E1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2E1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component BSK_LPS_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
TOX21_p53_BLA_p5_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component ATG_HSE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HSE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HSF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein.
Data from the assay component ATG_DR5_RAR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_DR5_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA and RARB and RARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component BSK_4H_Pselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_Pselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELP. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.
Data from the assay component BSK_4H_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
TOX21_HSE_BLA_Agonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component BSK_3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.
Data from the assay component BSK_BE3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.
Data from the assay component BSK_LPS_PGE2 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_PGE2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PTGER2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.
Data from the assay component BSK_hDFCGF_PAI1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_PAI1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator inhibitor.
Data from the assay component BSK_KF3CT_MMP9 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_MMP9, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.
Data from the assay component BSK_LPS_TNFa was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_TNFa, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TNF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.
Data from the assay component BSK_SAg_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component ATG_CRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CREB3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
Data from the assay component LTEA_HepaRG_UGT1A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_UGT1A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is glucuronosyltransferase.
Data from the assay component BSK_BE3C_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component TOX21_AR_LUC_MDAKB2_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_p53_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_p53_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TP53. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.
Data from the assay component OT_AR_ARSRC1_0960 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0960, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component BSK_SAg_PBMCCytotoxicity was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_PBMCCytotoxicity, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the viability. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component BSK_3C_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component TOX21_RXR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RXR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where subfamily is NF-kappa B.
Data from the assay component ATG_IR1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_IR1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component BSK_BE3C_MMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_MMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.
Data from the assay component BSK_LPS_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.
Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist, was analyzed in the positive analysis fitting direction relative to DHT as the baseline of activity. 

Using a type of binding reporter, measures of receptor for loss-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.
Data from the assay component ATG_NF_kB_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NF_kB_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFKB1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B.
Data from the assay component TOX21_HRE_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HRE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HIF1A. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is hypoxia-response element.
Data from the assay component BSK_hDFCGF_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component BSK_3C_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.
Data from the assay component BSK_3C_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.
Data from the assay component BSK_LPS_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component ATG_Sp1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Sp1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SP1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.
Data from the assay component BSK_4H_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component LTEA_HepaRG_CYP2C19 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C19, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component LTEA_HepaRG_CYP3A4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component ATG_E_Box_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_E_Box_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene USF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.
Data from the assay component BSK_4H_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component BSK_3C_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component BSK_SAg_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component APR_HepG2_CellLoss_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellLoss_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.
Data from the assay component BSK_4HAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_4HAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.
TOX21_ERa_BLA_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component BSK_LPS_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component BSK_KF3CT_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component BSK_hDFCGF_MMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.
Data from the assay component BSK_SAg_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component LTEA_HepaRG_FABP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FABP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is fatty acid carrier protein.
Data from the assay component OT_FXR_FXRSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component BSK_3C_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
Data from the assay component BSK_hDFCGF_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
The assay component endpoint  TOX21_SBE_BLA_Agonist_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.
The assay component endpoint  TOX21_CASP3_HEPG2 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. The TOX21_CASP3_HEPG2 assay is a homogeneous, luminescent assay that measures caspase-3 activity following compound treatment as an indicator of induction of apoptosis. Gain-of-signal activity can be used to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to apoptosis, where the subfamily is caspase.
Data from the assay component BSK_KF3CT_TIMP2 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_TIMP2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.
Data from the assay component BSK_CASM3C_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
Data from the assay component BSK_LPS_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component LTEA_HepaRG_CYP3A7 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A7, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component BSK_BE3C_PAI1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_PAI1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator inhibitor.
Data from the assay component BSK_LPS_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component LTEA_HepaRG_CYP4A11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP4A11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component BSK_LPS_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.
Data from the assay component LTEA_HepaRG_CYP7A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP7A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component BSK_KF3CT_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component BSK_CASM3C_Thrombomodulin was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_Thrombomodulin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.
TOX21_RAR_LUC_Antagonist_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
The assay component endpoint  TOX21_SBE_BLA_Antagonist_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.
TOX21_TRHR_HEK293_Antagonist  used a type of biochemical reporter where loss-of-signal activity can be used to understand changes in the receptor activation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.
Data from the assay component OT_ER_ERaERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_C_EBP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_C_EBP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CEBPB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
Data from the assay component LTEA_HepaRG_IGF1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IGF1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is insulin-like.
Data from the assay component ATG_NFI_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NFI_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFIA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear factor I.
Data from the assay component LTEA_HepaRG_CYP4A22 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP4A22, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component TOX21_PGC_ERR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PGC_ERR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.
Data from the assay component OT_AR_ARSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component LTEA_HepaRG_HMGCS2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HMGCS2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is HMG-CoA synthase.
Data from the assay component BSK_BE3C_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component TOX21_TSHR_HTRF_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this one serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.
Data from the assay component OT_FXR_FXRSRC1_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_ABCB11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCB11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.
Data from the assay component BSK_hDFCGF_TIMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_TIMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.
Data from the assay component BSK_LPS_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.
Data from the assay component BSK_CASM3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.
Data from the assay component BSK_BE3C_tPA was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_tPA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAT. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.
Data from the assay component TOX21_ESRE_BLA_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ATF6.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.
Data from the assay component BSK_CASM3C_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.
Data from the assay component LTEA_HepaRG_PEG10 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PEG10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component BSK_KF3CT_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component LTEA_HepaRG_PDK4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PDK4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.
Data from the assay component LTEA_HepaRG_SLC22A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC22A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic cation transporter.
Data from the assay component ATG_PPARa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component BSK_BE3CA was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3CA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.
Data from the assay component LTEA_HepaRG_ABCB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.
Data from the assay component LTEA_HepaRG_THRSP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_THRSP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is NR mediated metabolism.
Data from the assay component LTEA_HepaRG_FASN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FASN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is fatty acid synthase.
Data from the assay component TOX21_ERR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.
Data from the assay component BSK_KF3CTA was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CTA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.
Data from the assay component BSK_CASM3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.
Data from the assay component TOX21_RAR_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RAR_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RARA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.
Data from the assay component BSK_BE3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.
Data from the assay component OT_ER_ERaERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component LTEA_HepaRG_ABCC2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCC2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.
Data from the assay component OT_ER_ERbERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component TOX21_PPARg_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_Sox_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Sox_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SOX1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein.
Data from the assay component LTEA_HepaRG_CYP2C8 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component OT_ER_ERbERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component BSK_CASM3C_IL6 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_IL6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component LTEA_HepaRG_FMO3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FMO3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is dioxygenase.
Data from the assay component BSK_CASM3C_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component LTEA_HepaRG_KRT19 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KRT19, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the filaments intended target family, where the subfamily is keratin.
Data from the assay component APR_HepG2_CellLoss_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellLoss_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.
Data from the assay component TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component OT_NURR1_NURR1RXRa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_SULT2A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SULT2A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is sulfotransferase.
Data from the assay component ATG_AP_2_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AP_2_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TFAP2A and TFAP2B and TFAP2D. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-turn-helix leucine zipper.
Data from the assay component LTEA_HepaRG_APOA5 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_APOA5, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the apolipoprotein intended target family, where the subfamily is Steatosis.
Data from the assay component BSK_CASM3C_LDLR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_LDLR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene LDLR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the misc protein intended target family, where the subfamily is LDL receptor.
Data from the assay component BSK_KF3CT_TGFb1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_TGFb1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.
Data from the assay component BSK_KF3CT_ICAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
Data from the assay component LTEA_HepaRG_LPL was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LPL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is lipase.
Data from the assay component LTEA_HepaRG_GSTA2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GSTA2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is alkyl and aryl transferase.
Data from the assay component TOX21_PR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_TGFb_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TGFb_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TGFB1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.
Data from the assay component LTEA_HepaRG_ABCG2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCG2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.
Data from the assay component TOX21_PPARd_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_LIPC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LIPC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is lipase.
Data from the assay component BSK_CASM3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component LTEA_HepaRG_ALPP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ALPP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_ACOX1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ACOX1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidase intended target family, where the subfamily is steatosis.
Data from the assay component ATG_NRF1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NRF1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NRF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear respiratory factors.
Data from the assay component BSK_CASM3C_SAA was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_SAA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is apolipoproteins.
Data from the assay component BSK_KF3CT_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component BSK_CASM3C_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.
Data from the assay component ATG_Myc_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Myc_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.
Data from the assay component LTEA_HepaRG_DDIT3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_DDIT3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
Data from the assay component APR_HepG2_MitoticArrest_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MitoticArrest_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.
Data from the assay component BSK_4H_VEGFRII was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_VEGFRII, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.
Data from the assay component LTEA_HepaRG_CAT was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CAT, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the catalase intended target family, where the subfamily is oxidative stress.
Data from the assay component BSK_3C_Thrombomodulin was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Thrombomodulin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.
Data from the assay component BSK_SAg_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component OT_ERa_GFPERaERE_0120 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0120, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component LTEA_HepaRG_GADD45A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Oxidative Stress.
Data from the assay component BSK_BE3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component ATG_Ets_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Ets_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ETS1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is winged helix-turn-helix.
Data from the assay component OT_ERa_GFPERaERE_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component LTEA_HepaRG_CYP2C9 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C9, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist, was analyzed in the positive analysis fitting direction relative to DHT as the baseline of activity. 

Using a type of binding reporter, measures of receptor for loss-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.
Data from the assay component LTEA_HepaRG_IGFBP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IGFBP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is hormone carrier protein.
Data from the assay component LTEA_HepaRG_MYC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MYC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.
Data from the assay component OT_NURR1_NURR1RXRa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_GADD45G was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45G, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mutagenicity response intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component ATG_NURR1_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NURR1_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR4A2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.
Data from the assay component BSK_3C_ICAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
Data from the assay component LTEA_HepaRG_SLCO1B1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLCO1B1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic anion transporter.
Data from the assay component LTEA_HepaRG_MMP3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MMP3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.
Data from the assay component BSK_hDFCGF_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component LTEA_HepaRG_UGT1A6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_UGT1A6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is glucuronosyltransferase.
Data from the assay component APR_HepG2_P-H2AX_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_P-H2AX_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is cellular response to DNA damage stimulus.
Data from the assay component ATG_GLI_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GLI_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GLI1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.
TOX21_TRHR_HEK293_Agonist  used a type of biochemical reporter where gain-of-signal activity can be used to understand changes in the receptor activation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.
Data from the assay component BSK_BE3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component LTEA_HepaRG_STAT3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_STAT3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein.
Data from the assay component LTEA_HepaRG_NFE2L2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NFE2L2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
Data from the assay component APR_HepG2_CellCycleArrest_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellCycleArrest_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.
Data from the assay component LTEA_HepaRG_IL6R was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IL6R, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is JAK-STAT cytokine receptor.
Data from the assay component LTEA_HepaRG_HSPA1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HSPA1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein.
Data from the assay component LTEA_HepaRG_ACLY was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ACLY, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is steatosis.
Data from the assay component LTEA_HepaRG_MIR122 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MIR122, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the microrna intended target family, where the subfamily is post-transcriptional regulation.
Data from the assay component BSK_3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component LTEA_HepaRG_GADD45B was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45B, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mutagenicity response intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_GCLM was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GCLM, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ligase intended target family, where the subfamily is C-N ligase.
Data from the assay component BSK_hDFCGF_EGFR was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_EGFR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.
Data from the assay component APR_HepG2_P-H2AX_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_P-H2AX_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is cellular response to DNA damage stimulus.
Data from the assay component LTEA_HepaRG_TNFRSF1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TNFRSF1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is TNF receptor.
Data from the assay component LTEA_HepaRG_CYP3A5 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A5, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component BSK_CASM3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.
Data from the assay component LTEA_HepaRG_TP53 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TP53, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.
Data from the assay component ATG_FoxO_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FoxO_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXO1 and FOXO3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.
TOX21_HDAC_Inhibition_viability used a type of viability reporter where loss-of-signal activity can be used to understand changes in the cell viability. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.
Data from the assay component BSK_BE3C_TGFb1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_TGFb1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.
Data from the assay component LTEA_HepaRG_FOXO3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FOXO3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.
Data from the assay component OT_ER_ERaERa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component OT_ER_ERaERa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_HNF6_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HNF6_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ONECUT1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is homeobox protein.
Data from the assay component TOX21_FXR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_BCL2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BCL2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_IL6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IL6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component APR_HepG2_p53Act_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_p53Act_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.
Data from the assay component LTEA_HepaRG_CCND1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CCND1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_GCLC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GCLC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ligase intended target family, where the subfamily is C-N ligase.
Data from the assay component APR_HepG2_MitoticArrest_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MitoticArrest_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.
Data from the assay component ATG_GRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the baseline of activity. 

Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.
Data from the assay component LTEA_HepaRG_NFKB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NFKB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B.
Data from the assay component LTEA_HepaRG_BCL2L11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BCL2L11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_EGR1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EGR1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.
Data from the assay component BSK_CASM3C_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.
Data from the assay component LTEA_HepaRG_CDKN1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CDKN1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_LDH_cytotoxicity was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LDH_cytotoxicity, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for loss-of-signal activity can be used to understand cell death. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.
Data from the assay component APR_HepG2_CellCycleArrest_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellCycleArrest_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.
The assay component endpoint  TOX21_CASP3_CHO was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. The TOX21_CASP3_CHO assay is a homogeneous, luminescent assay that measures caspase-3 activity following chemical treatment as an indicator of induction of apoptosis. Gain-of-signal activity can be used to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to apoptosis, where the subfamily is caspase.
Data from the assay component TOX21_ERb_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component LTEA_HepaRG_CFLAR was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CFLAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_BID was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BID, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_HIF1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HIF1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.
Data from the assay component APR_HepG2_p53Act_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_p53Act_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.
Data from the assay component LTEA_HepaRG_XBP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_XBP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
Data from the assay component LTEA_HepaRG_ABCC3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCC3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.
Data from the assay component LTEA_HepaRG_ADK was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ADK, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is steatosis.
Data from the assay component LTEA_HepaRG_FAS was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FAS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is TNF receptor.
Data from the assay component LTEA_HepaRG_FOXO1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FOXO1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.
Data from the assay component ATG_E2F_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_E2F_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene E2F1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is E2F transcription factor.
Data from the assay component OT_AR_ARELUC_AG_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARELUC_AG_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component APR_HepG2_MitoMembPot_24hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMembPot_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.
Data from the assay component LTEA_HepaRG_PPP2R4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PPP2R4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is serine/threonine phosphatase.
Data from the assay component LTEA_HepaRG_ICAM1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.
Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the baseline of activity. 

Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.
Data from the assay component LTEA_HepaRG_TGFB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TGFB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.
Data from the assay component TOX21_NFkB_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_NFkB_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is NF-kappa B.
Data from the assay component LTEA_HepaRG_SDHB was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SDHB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is ubiquinone.
Data from the assay component ATG_Myb_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Myb_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is MYB proteins.
Data from the assay component APR_HepG2_MitoMass_72hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMass_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.
Data from the assay component LTEA_HepaRG_EZR was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EZR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the membrane protein intended target family, where the subfamily is Cellular remodeling.
Data from the assay component LTEA_HepaRG_MMP10 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MMP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.
Data from the assay component APR_HepG2_MicrotubuleCSK_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component TOX21_ELG1_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ELG1_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATAD5.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is atpase.
Data from the assay component LTEA_HepaRG_TGFA was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TGFA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is EGF-like domain.
Data from the assay component LTEA_HepaRG_BAX was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BAX, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component LTEA_HepaRG_EGF was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EGF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is EGF-like domain.
Data from the assay component LTEA_HepaRG_CASP3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CASP3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.
Data from the assay component ATG_FoxA2_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FoxA2_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXA2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.
Data from the assay component ATG_GATA_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GATA_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GATA1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is GATA proteins.
Data from the assay component APR_HepG2_MitoMass_24hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMass_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.
Data from the assay component LTEA_HepaRG_PTEN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PTEN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is dual-specific phosphatase.
Data from the assay component ATG_STAT3_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_STAT3_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene STAT3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein.
Data from the assay component ATG_FXR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FXR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_JUN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_JUN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.
Data from the assay component APR_HepG2_MicrotubuleCSK_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.
Data from the assay component LTEA_HepaRG_TIMP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TIMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.
Data from the assay component LTEA_HepaRG_HGF was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HGF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is hepatocyte growth factor.
Data from the assay component ATG_THRa1_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_THRa1_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene THRA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ACEA_AR_agonist_80hr was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, measures of the cells for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the geneAR 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component LTEA_HepaRG_KCNK1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KCNK1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is potassium channel.
Data from the assay component LTEA_HepaRG_GSTM3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GSTM3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is alkyl and aryl transferase.
Data from the assay component LTEA_HepaRG_CASP8 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CASP8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.
Data from the assay component ATG_RXRa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RXRa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_NQO1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NQO1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is quinone-acceptor.
Data from the assay component APR_HepG2_MitoMembPot_72hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMembPot_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.
Data from the assay component APR_HepG2_StressKinase_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_StressKinase_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is stress response.
Data from the assay component TOX21_VDR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_PPARd_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARd_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARD. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_LXRa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_LXRa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_GR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component ATG_RARa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_LXRb_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_LXRb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component APR_HepG2_StressKinase_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_StressKinase_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is stress response.
Data from the assay component ATG_RARg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_VDR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_VDR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_AR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.
Data from the assay component TOX21_TSHR_HTRF_wt_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_wt_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.
Data from the assay component APR_HepG2_NuclearSize_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_NuclearSize_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.
Data from the assay component ATG_HNF4a_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HNF4a_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HNF4A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.
Data from the assay component APR_HepG2_NuclearSize_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_NuclearSize_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.
Data from the assay component TOX21_SBE_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor receptor intended target family, where subfamily is transforming growth factor beta.
Data from the assay component LTEA_HepaRG_BAD was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BAD, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.
Data from the assay component TOX21_SHH_3T3_GLI3_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SHH_3T3_GLI3_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GLI3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.
Data from the assay component ATG_CAR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CAR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component LTEA_HepaRG_CYP24A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP24A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.
Data from the assay component OT_PPARg_PPARgSRC1_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_PPARg_PPARgSRC1_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene PPARG. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component OT_PPARg_PPARgSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_PPARg_PPARgSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene PPARG. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_RARb_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.
Data from the assay component ATG_RORg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RORg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.
Data from the assay component ATG_ERRg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERRg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESRRG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.